免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

HOLT-ED: Holter-monitoring in End-stage Renal Disease

NCT:NCT04876963 · COMPLETED

NCT编号NCT04876963
状态COMPLETED
开始日期2021-09-01
完成时间2025-12-31
SponsorRigshospitalet, Denmark (OTHER)
First posted
Last updated

简要摘要

The main objective of this prospective cohort study is to assess arrhythmia burden and glycemic variability in a multicenter cohort of patients with end-stage renal disease using a sufficient observation period in order to identify arrhythmia burden and type and characterize associations with patient characteristics and dialysis treatment, glycemic variability and subsequent risk of adverse outcomes.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑